PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pioglitazone Hydrochloride And Metformin Hydrochloride, and when can generic versions of Pioglitazone Hydrochloride And Metformin Hydrochloride launch?
Pioglitazone Hydrochloride And Metformin Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Chartwell Rx, Macleods Pharms Ltd, Norvium Bioscience, Teva Pharms Usa, and Torrent Pharms Ltd. and is included in six NDAs.
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There are forty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE?
- What are the global sales for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE?
- What is Average Wholesale Price for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE?
Summary for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 155 |
| Patent Applications: | 36 |
| DailyMed Link: | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Minnesota | Phase 2 |
| Nanjing First Hospital, Nanjing Medical University | Phase 3 |
| Affiliated Hospital of Nantong University | Phase 1 |
See all PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE clinical trials
Pharmacology for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
US Patents and Regulatory Information for PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; pioglitazone hydrochloride | TABLET;ORAL | 200823-001 | Feb 13, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Norvium Bioscience | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; pioglitazone hydrochloride | TABLET;ORAL | 090406-001 | Feb 25, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | metformin hydrochloride; pioglitazone hydrochloride | TABLET;ORAL | 091273-002 | Apr 16, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
